U.S. FDA inspection at Glenmark Pharmaceuticals Ltd's Facility at Chhatrapati Sambhaji Nagar, India

The U.S. FDA has issued Form 483 with zero observations after an inspection at Glenmark Pharmaceuticals Limited's formulation manufacturing facility based out of Chhatrapati Sambhaji Nagar (Aurangabad), India between September 09 and September 20, 2024.

Shares of Glenmark Pharmaceuticals Limited was last trading in BSE at Rs. 1651.15 as compared to the previous close of Rs. 1645.05. The total number of shares traded during the day was 8689 in over 1279 trades.

The stock hit an intraday high of Rs. 1676.50 and intraday low of 1626.70. The net turnover during the day was Rs. 14308298.00.

Source : Equity Bulls

Keywords

GlenmarkPharmaceuticals INE935A01035 USFDA Form483 ZeroObservation Inspection